Cargando…

COVID-19 and the Renin Angiotensin System: Implications for the Older Adults

Detalles Bibliográficos
Autor principal:	Bahat, Gülistan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Paris 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271637/ https://www.ncbi.nlm.nih.gov/pubmed/32744564 http://dx.doi.org/10.1007/s12603-020-1403-7

Ejemplares similares

Renin–Angiotensin System Implications to COVID-19 Comorbidities
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

The systemic renin-angiotensin system in COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

Renin-angiotensin system at the heart of COVID-19 pandemic
por: Alifano, Marco, et al.
Publicado: (2020)

Renin-angiotensin system at the interface of COVID-19 infection
por: Gul, Rukhsana, et al.
Publicado: (2021)

Quantifying Renin-Angiotensin-System Alterations in COVID-19
por: Pucci, Fabrizio, et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Renin-angiotensin system inhibition in COVID-19 patients
por: de Vries, A. A. F.
Publicado: (2020)

COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
por: Amraei, Razie, et al.
Publicado: (2020)

Covid-19: the renin–angiotensin system imbalance hypothesis
por: Lanza, Katharina, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Renin Angiotensin System Inhibition as treatment for Covid-19?
por: Williams, Professor Bryan
Publicado: (2021)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020)

Higher failure of female older asthma patients in use of inhalants: is it due to older age and/or cognition problems?
por: Soyluk, Ozlem, et al.
Publicado: (2015)

Renin-Angiotensin System Inhibitors in COVID-19: Current Concepts
por: Mahajan, Kunal, et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
por: Reynolds, Harmony R., et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

The renin–angiotensin system: An integrated view of lung disease and coagulopathy in COVID-19 and therapeutic implications
por: Diamond, Betty
Publicado: (2020)

Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update
por: Shukla, Ashwin Kumar, et al.
Publicado: (2021)

The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
por: Sainz-Cort, Alberto, et al.
Publicado: (2020)

Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
por: Ababei, Daniela-Carmen, et al.
Publicado: (2023)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Physical Exercise and the Renin Angiotensin System: Prospects in the COVID-19
por: Evangelista, Fabiana S.
Publicado: (2020)

Renin–angiotensin system inhibitors and mortality in patients with COVID-19
por: Rossi, Luca, et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Risk of Covid-19 with renin-angiotensin-aldosterone system medications
Publicado: (2020)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Renin-angiotensin system inhibitors in hospitalised patients with COVID-19
por: Williams, Bryan
Publicado: (2021)

COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy
por: Babajani, Fatemeh, et al.
Publicado: (2021)

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
por: Labandeira-Garcia, Jose L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s1ddc07ud8tumao1e371ceo72g